Alerts will be sent to your verified email
Verify Email
SYSCHEM
|
Syschem (India)
|
Bal Pharma
|
Bafna Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-19.23 % | 1.96 % | -52.11 % |
|
5yr average Equity Multiplier
|
6.28 | 4.59 | 3.77 |
|
5yr Average Asset Turnover Ratio
|
1.15 | 0.98 | 0.42 |
|
5yr Avg Net Profit Margin
|
-1.61 % | -0.04 % | -36.55 % |
|
Price to Book
|
3.21 | 2.51 | 3.52 |
|
P/E
|
0.0 | 23.84 | 41.81 |
|
5yr Avg Cash Conversion Cycle
|
-2.55 Days | 41.77 Days | 0.18 Days |
|
Inventory Days
|
94.02 Days | 106.16 Days | 87.65 Days |
|
Days Receivable
|
86.28 Days | 104.16 Days | 132.64 Days |
|
Days Payable
|
176.28 Days | 132.37 Days | 210.48 Days |
|
5yr Average Interest Coverage Ratio
|
-19.05 | 1.22 | -5.68 |
|
5yr Avg ROCE
|
-3.72 % | 15.4 % | -11.61 % |
|
5yr Avg Operating Profit Margin
|
0.88 % | 7.79 % | -21.98 % |
|
5 yr average Debt to Equity
|
0.82 | 2.03 | 1.41 |
|
5yr CAGR Net Profit
|
n/a | n/a | 12.0 % |
|
5yr Average Return on Assets
|
-1.4 % | 0.43 % | -16.11 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
57.02 % | 50.86 % | 75.0 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
40.68 % | 1.29 % | -15.42 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Syschem (India)
|
Bal Pharma
|
Bafna Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|